No takes yet. Share an insight, caveat, or question.
Randomized trial evaluates antibacterial efficiency of green-synthesized Fe3O4 nanoparticles in pathogens, suggesting potential biomedical applications.
Sager et al. (2026) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: